These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35988276)

  • 1. Prognostic value of combining E-cadherin, p53, Bcl-2 and Bcl-xL expression and survival in Tunisian colorectal adenocarcinoma patients.
    Jamai D; Kallel I; Mekrezi S; Walha M; Gharsallah M; Khabir A; Selmi B
    Cell Mol Biol (Noisy-le-grand); 2022 Apr; 68(4):93-107. PubMed ID: 35988276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical expression of bcl-2, bcl-xL, bax, p53 proteins in gastric adenoma and adenocarcinoma].
    Lee DS; Kang SB; Baek JT; Nam SW; Lee KM; Ahn BM; Lee EH; Han SW; Chung IS
    Korean J Gastroenterol; 2005 Jun; 45(6):394-400. PubMed ID: 15973073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
    Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Factors of Prostate Cancer in Tunisian Men: Immunohistochemical Study.
    Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
    Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.
    Manne U; Myers RB; Moron C; Poczatek RB; Dillard S; Weiss H; Brown D; Srivastava S; Grizzle WE
    Int J Cancer; 1997 Jun; 74(3):346-58. PubMed ID: 9221816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
    Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
    Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
    Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas.
    Ayed DB; Khabir A; Abid M; Bayrouti MI; Gargouri A; Sellami-Boudawara T; Mokdad-Gargouri R
    Acta Histochem; 2014 Oct; 116(8):1244-50. PubMed ID: 25095748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of COX-2 and E-cadherin in Tunisian patients with colorectal adenocarcinoma.
    Miladi-Abdennadher I; Abdelmaksoud-Dammak R; Ayed-Guerfali DB; Ayadi L; Khabir A; Amouri A; Frikha F; Tahri N; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
    Acta Histochem; 2012 Oct; 114(6):577-81. PubMed ID: 22133296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
    Han HS; Park YM; Hwang TS
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Bcl-xL gene expression in human colorectal cancer.
    Jin-Song Y; Zhao-Xia W; Cheng-Yu L; Xiao-Di L; Ming S; Yuan-Yuan G; Wei D
    Acta Histochem; 2011 Dec; 113(8):810-4. PubMed ID: 21277008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.
    Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
    Gynecol Endocrinol; 2018 Feb; 34(2):171-174. PubMed ID: 28937296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.
    Nariculam J; Freeman A; Bott S; Munson P; Cable N; Brookman-Amissah N; Williamson M; Kirby RS; Masters J; Feneley M
    Asian J Androl; 2009 Jan; 11(1):109-18. PubMed ID: 19050681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor substrate 1 may play divergent roles in human colorectal cancer development and progression.
    Lomperta K; Jakubowska K; Grudzinska M; Kanczuga-Koda L; Wincewicz A; Surmacz E; Sulkowski S; Koda M
    World J Gastroenterol; 2020 Jul; 26(28):4140-4150. PubMed ID: 32821075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
    Gurzu S; Jung J; Mezei T; Pávai Z
    Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of E-cadherin and bcl-2 on prognosis in patients with breast cancer.
    Kavgaci H; Yildiz B; Fidan E; Reis A; Ozdemir F; Cobanoglu U; Can G
    Bratisl Lek Listy; 2010; 111(9):493-7. PubMed ID: 21180263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of E-cadherin and Cox 2 expression in Tunisian patients with colorectal mucinous adenocarcinoma.
    Triki M; Kallel R; Feki J; Mellouli M; Charfi S; Ayadi L; Boudawara T
    Ann Diagn Pathol; 2020 Dec; 49():151624. PubMed ID: 32919337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.